MSB Docs for Pharmaceuticals

Digitize your document workflow processes with 21 CFR compliant eSignature solutions.

Request a demo
Faster-turnaround-time

12h

Per week saved

file-check

78%

Fast Signature Approval

Reduced-costs-law

100%

21 CFR Part 11 compliant

Enhance Clinical & Quality Operations Efficiency

Whether patient consent or vendor contracts, MSB Docs’ eSignature solutions help pharmaceutical organizations maximize efficiency, flexibility, and ease of use.

Secure Workflows with 21 CFR Part 11 Compliance

MSB Docs enterprise eSignature solution provides FDA-compliant signatures and records that enhance quality management and collaboration capabilities.

Pharmacetutical-Lifecycle
  • Scales with your use cases
    MSB Docs’ out-of-the-box validation ensures accuracy, reliability, and consistency, adhering to FDA regulations.
  • Intuitive UI and API
    The audit trail records the document’s date, timestamp, location, and actions that cannot be modified.
  • Track Documents
    Audited and certified against the most rigorous security certifications, including 21 CFR Part 11 and HIPAA regulations.
  • Trusted & Secure
    Scale your Document workflows with advanced integration with eTMF, eQMS, and DMS systems.

Ensuring the Reliability & Security of Electronic Records

MSB Docs uses procedures and controls to ensure the authenticity, integrity, and confidentiality of electronic records from the time they are created until they are received.

Use cases

Pharmaceutical companies use MSB docs to sign documents, approvals, and agreements, including:

  • blueCheck Clinical trial onboarding
  • blueCheck Patient consent form
  • blueCheck Patient contracts
  • blueCheck Vendor contracts
  • blueCheck Sales agreements
  • blueCheck ID verification
  • blueCheck Patient assistance documents
use-cases-in-the-Pharmaceutical-industry

Security and Regulatory Compliance

We make sure that your documents are signed, shared, and saved with several levels of security.

FDA
PNG_GDPR
Hippa
AICPA
CCPA
eu-us

Our clients accelerating workflows with MSB Docs

icon-pharma
Pfizer-pharma
gsk-pharma
Roche-Pharma
glenmark
johnson

Start Digitizing Your Workflows With MSB Docs

FAQs

Offering maximum customer support is of the utmost value for any company. The pharmaceutical industry is no exception. eSignatures can offer far better solutions to patients when trying to get medicines. Pharmaceutical businesses need to cooperate with hospitals. Often, a hospital must order in fast stock of drugs to manage patients struggling with particular health problems. Suppose the hospital can directly order medications using electronic prescription documents with eSignatures. In that case, the paperwork will undoubtedly be very quickly processed by the drug store, leading to the faster purchase of the medicines. By doing this, the patient will instantly obtain the medication they need.

Envision that there is an immediate requirement for medication for a patient, but its purchase is hindered by management using the old approach and still depending on paper records. This method takes a very long time and leads to huge operational costs. Most significant global pharmaceutical companies have felt the positive impact of eSignatures. Many companies have witnessed that around 85% of their documents could be completed using eSignatures in one day. Throughout the pandemic, speed has been essential because of the overwhelming demand for medications from the pharmaceutical businesses.

Time can be saved by using eSignatures for drug distribution, and administration of sales documents assists drug sales. For bigger pharmaceutical businesses, the speed of document processing can help sales processes worldwide. That is the experience of one significant eSignature in medicine sales agreements.

eSignatures can enhance a company’s credibility, focusing on information security, speed, and better service experience. In the past two years, pharmaceutical companies have implemented them in nearly 80 nations to improve solutions to better sales.

eSignatures are lawfully allowed in the pharmaceutical industry with the condition that they comply with specific guidelines under the Uniform Electronic Transaction Act and the Esign Act to make it HIPAA compliant.